ICON announced PMG Research and DuPage Medical Group have finalized a Master Agreement formalizing a clinical research partnership. Effective May 2018, PMG Research will assume the research infrastructure at the DuPage Medical Group.
The expansion of the PMG Research network enhances ICON’s ability to increase access and engagement with investigator sites and patients, helping customers to reduce the overall time and cost associated with drug development. The addition of DuPage Medical Group provides investigator and patient access in the greater Chicago area, while bringing clinical research as a care option to the communities served.
“Enrolling and engaging patients in clinical trials continues to be one of the biggest challenges within drug development. Our partnership with DuPage Medical Group extends our ability to help customers enhance clinical trial feasibility and improve patient enrolment timelines whilst also giving patients access to a broader range of care options through clinical trials.” Commented EB McLindon, Senior Vice President, Site & Patient Recruitment, ICON. “We are committed to enhancing engagement with sites, patients and healthcare providers to take significant time and cost from our customers’ development programs.”